VNDA · US market

Vanda Pharmaceuticals Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$290.83mFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-1.06×

Latest-quarter run-rate P/E-1.16×

Trailing P/S1.35×

Latest-quarter run-rate P/S1.44×

Calculation inputs

Trailing earnings: -US$274.85m
Latest-quarter run-rate earnings: -US$250.05m
Latest fiscal-year earnings: -US$220.47m
Trailing revenue: US$215.72m
Latest-quarter run-rate revenue: US$202.12m
Latest fiscal-year revenue: US$216.11m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

IBRN · iShares Neuroscience and Healthcare ETF0.30% weight · Holdings dated 21 August 2026
QQQS · Invesco NASDAQ Future Gen 200 ETF0.29% weight · Holdings dated 31 May 2026
VSFAX · Federated Hermes MDT Small Cap Value Fund Class A0.21% weight · Holdings dated 30 June 2026
QASCX · Federated Hermes MDT Small Cap Core Fund Class A0.16% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
SQLV · Royce Quant Small-Cap Quality Value ETF0.15% weight · Holdings dated 30 June 2026
BRSDX · MFS Blended Research Small Cap Equity Fund Class A0.13% weight · Holdings dated 31 May 2026
SWSCX · Schwab Small-Cap Equity Fund0.13% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
VFMFX · Vanguard U.S. Multifactor Fund Admiral Shares0.11% weight · Holdings dated 30 June 2026
XBI · State Street SPDR S&P Biotech ETF0.11% weight · Holdings dated 21 August 2026
WSMVX · Wilshire Small Company Value Fund Class Institutional0.10% weight · Holdings dated 30 June 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.